As the father of the patient is a paramedic and serving in the same military hospital of Chattogram cantonment, with his medical skill, he made an effort to prevent the bleeding by pressure bandage over the injury site in several times and the bleeding decreased meaningfully. After that, the child dozed but at about 0100 hours on 19 th January 2018, the parents noticed that bleeding resumed and blood wetted the bed and mouth of the baby was filled with fresh blood. So, the parents took the baby and rushed to emergency and casualty department of the military hospital.
The attending doctor also examined the injury site and found that the injury was very trivial in nature. There was no need to stitch and he again tried to stop the bleeding by putting pressure bandage and antifibrinolytic agents (tranexamic acid). Initially, the bleeding stopped but after 5-10 min, the bleeding again started. Then he referred the patient to the Military Dental Center. I attended the patient and found that the blood was oozing from the injury site. I again tried to stop the bleeding by putting pressure bandage and local anesthetic agent such as injection adrenaline but it did not work rather more bleeding was observed from the injection site. Then I put hemostatic paste to the injury site and bleeding stopped. As per statement of the parents, the baby was delivered by cesarean section and the baby was otherwise healthy until this incident as well as the mother recovered well after cesarean section with no history of prolonged bleeding peri-and post-operatively. Her father also underwent operation for deviated nasal septum and recovered well. The patient was immunized as per national immunization schedule and her milestone of development was age proportional. However, during vaccination, the bleeding was observed and it took slightly long time to stop and as it was so minor abnormality that the parents ignored it and did not bring to the notice of the concerned physician. The baby did not suffer from any serious medical and surgical illness in the past. The patient is the only daughter of the parents. Family history revealed no record of bleeding disorder. On general and systemic examinations, no abnormality was detected. No abnormality was detected in the dentures, oral mucosa, gum, lips and tongue on local examination other than a 1 x 1 x 1 cm 3 wound in the upper labial frenum. As such, abnormal bleeding from the upper labial frenum was unrelated to dental disorders. Therefore, I referred the case to the child specialist as well as hematologist for further management.
Dr. Bazlur Rahman (Pediatricians):
The referred case had reported to the outpatient department of Pediatrics in the morning on 19 th January 2018. We discussed the case together and assumed that it might be a case of congenital bleeding disorder. Therefore, we advised for complete blood count, blood grouping, bleeding time, clotting time, prothrombin time and partial thromboplastin time for both the patient as well as parents. The patient was also advised to do serum TSH.
On 20 th January 2018, we got the results of the laboratory investigations which showed marked prolongation of bleeding time and partial thromboplastin time of the patient but all other investigations of the patient and parents were within normal limits. Results of the laboratory investigations of the parents were within normal limits. Blood group of the patient was B positive, father O positive and mother B positive. Basing on the history, physical findings and results of the laboratory investigation, we made an interim clinical impression and referred the case to a tertiary care military hospital, Dhaka cantonment, Dhaka, Bangladesh.
Dr. Mohammad Mizanur Rahman (Hematologist):
After reporting to me, I have re-evaluated the case and carefully dissected the history, family pedigree, physical findings and laboratory investigations so far done. As the patient presented only with prolonged and excessive bleeding from the upper labial frenum, no family history of bleeding disorders, platelet count was 440,000/cmm, bleeding time was 20 min and PTT was 60 sec, so my clinical impression was Von Willebrand disease. I referred the case to army referral laboratory, Dhaka cantonment, Dhaka, Bangladesh for von Willebrand factor antigen and factor VIII assay.
Provisional Diagnosis
Inherited bleeding disorder
Differential Diagnosis
Dr. Rahman: Several factors were considered while constructing the differential diagnosis. First, age and sex of the patient. Second, sudden onset of prolonged and excessive bleeding following minor trauma. Third, consanguineous marriage of the parents and absence of bleeding disorders in the family. Fourth, results of first line coagulation tests and blood group of the patient. Fifth, pedigree analysis. Keeping such factors in mind and after evaluating the clinical and initial laboratory investigations, the following differential diagnoses were considered.
Immune thrombocytopenic purpura
Immune thrombocytopenic purpura is defined as low platelet count with either normal bone marrow or megakaryocytic hyperplasia in bone marrow and absence of other causes of thrombocytopenia. Patients with immune thrombocytopenic purpura presents with distinct purpuric rash, an increased tendency to bleed, easy bruising and ecchymoses in the skin and mucous membrane. 1 Immune thrombocytopenic purpura may be presented as acute in which children are mainly affected and usually follows a viral infection of the upper respiratory tract.
Acute immune thrombocytopenic purpura usually resolves spontaneously within two months. Chronic immune thrombocytopenic purpura usually occurs in adults without a known etiology and persists longer than six months. 2 Acute immune thrombocytopenic purpura in children is usually mild and self-limited but life threatening intracranial hemorrhage may occur when the platelet count is less than 10,000/cmm. 3 Such grave situation may be experienced in day to day practice in about 0.5-1.0% cases. However, half of these cases are fatal. 4 In immune thrombocytopenia, platelets are destroyed in the peripheral circulation through an immune mediated mechanism. An abnormal auto-antibody, usually IgG with specificity for platelet membrane glycolprotein IIb-IIIA or Ib-IX is produced and binds to circulating platelets. 5-7 Such antibody coated platelets are destroyed through Fc-mediated phagocytosis by mononuclear macrophages, primarily but not exclusively in the spleen. 8 Spleen plays a significant role in the pathogenesis of immune thrombocytopenic purpura, not only because platelet autoantibodies are produced in the white pulp but also because mononuclear macrophages in the red pulp phagocytes and destroy immunoglobulin-coated platelets. 9 In about 60 percent of cases, auto- antibodies against platelets are detected. 10 The incidence of immune thrombocytopenia has seasonal variation, with a peak in winter and a nadir in summer. Persistence or chronicity occurred in 36% of children compared with 67% of adults. 11 Immune thrombocytopenic purpura is more common in boys than in girls in case of children. 12 Usually women are prone to be affected more than men when immune thrombocytopenic purpura occurs in middle-aged individuals. 3 The peak incidence of immune thrombocytopenic purpura in children is between 1-6 years whereas in adults it may occur at any age but most cases are diagnosed in between 30 -40 years of age. 12 In this case, the age of the patient and presence of superficial bleeding suggests the diagnosis of immune thrombocytopenic purpura but sex of the patient, absence of previous history of infection, normal platelet count and no purpura and ecchymoses are the points against the diagnosis of immune thrombocytopenic purpura.
Acute leukemia
Acute leukemia is a neoplasm of bone marrow hemopoietic stem cells which proliferate uncontrolled and replace the normal hemopoietic cells of the marrow. According to cell line involved, acute leukemias are divided into two groups-acute myeloblastic leukemia and acute lymphoblastic leukemia. 13 Acute lymphoblastic leukemia is more frequent form of leukemia in children and comprises 75% of pediatric leukemia cases. Regarding the etiology of acute leukemia, very little is known and most patients have no identifiable risk factors. However, radiation exposure predisposes to the development of acute myeloblastic leukemia rather than acute lymphoblastic leukemia. Patients having prior history of Hodgkin lymphoma, small cell carcinoma and ovarian cancer are more susceptible to develop acute myeloblastic leukemia. 14 The incidence of acute lymphoblastic leukemia is also low among children with high level of social activity, especially those attending early daycare nursery than those living in more isolated communities and have a reduced exposure to common infections in the first year of life. 21 The presence of gum bleeding in this patient favors the diagnosis of acute lymphoblastic leukemia but absence of anemia, fever, lymphadenopathy and organomegaly, no immature white cell in peripheral blood as well as normal platelet count disfavors the diagnosis of acute lymphoblastic leukemia.
Aplastic anemia
Peripheral blood pancytopenia and bone marrow hypoplasia in the absence of abnormal infiltrate and without increase in reticulin are the features that define aplastic anemia. 22 In 1888, Paul Ehrlich introduced the concept of aplastic anemia but Anatole Chauffard named this disorder aplastic anemia in 1904. 23 It is thought that aplastic anemia is more common in Asia than the West. In Europe, the incidence is two cases per million population. 24 A prospective study conducted in Thailand revealed the incidence of approximately 4 to 6 cases per million populations. This increased incidence in this area may be due to more exposure to environmental factors such as pesticides, fertilizers, dying agents as well as toxic chemicals used in the garment and other industries. The increased incidence of aplastic anemia is not observed among the Asians living in United States indicating that genetic factors are more responsible for aplastic anemia in USA and the West. 25 No racial predisposition of aplastic anemia is reported in USA and both sexes are equally affected. Biphasic age distribution is observed with peaks at 20-25 years and another over 60 years. 22 The primary defects in or damage to the stem cells or the marrow microenvironment is the theoretical basis of bone marrow failure. Clinical and laboratory observations suggest that aplastic anemia is an autoimmune disease. 26- 28 In aplastic anemia, bone marrow examination revealed hemopoietic stem cell elements which are less than 25% and replaced by fat cells. CD34 cell population analyzed by flow cytometry are significantly reduced in the aplastic anemia. 29 However, in most cases of aplastic anemia, the cause is unknown. The search for an etiology is often unproductive and should obtain detailed work history including exposure to environmental factors as well as family and infectious disease history. 30 The chance of having inherited bone marrow failure is less in the absence of overt phenotypic features of inherited aplastic anemia such as Fanconi anemia, dyskeratosis congenita, Shwachman-Diamond syndrome, congenital amegakaryocytic thrombocytopenia, Bloom syndrome, Diamond-Blackfan syndrome. 31 The onset of aplastic anemia is usually insidious and usually presents with symptoms related to anemia, thrombocytopenia or signs of infection. Pallor, headache, palpitation, dyspnea, fatigue are the symptoms of anemia. Gingival bleeding, purpura, ecchymoses or petechial rashes occur due to thrombocytopenia.
Leucopenia, especially neutronpenia leads to mouth or pharyngeal ulceration, recurrent or overt infections with fever. Presence of lymphadenopathy or organomegaly as well as immature red or white cells in the peripheral blood film excludes the diagnosis of aplastic anemia. 32 Patient should also be searched for the presence of hyperpigmentation, short stature, malformations of the thumb and forearms, skeletal anomalies, small head or eyes, renal problems, hearing defect, heart disease, gastrointestinal difficulties and hypogonadism. 31 Aplastic anemia is diagnosed by blood and bone marrow studies. Peripheral blood examination usually shows pancytopenia or bicytopenia and bone marrow biopsy including aspiration is done to assess the cellularity of the bone marrow. Usually a hypoplastic marrow is found in aplastic anemia. Cytogenetic study and flow cytometric analysis of the bone marrow should be done to find out the genetic factors as well as the presence of PNH clone. 24 Therapy for aplastic anemia consists of supportive care only or immunosuppressive therapy or hemopoietic stem cell transplantation (HSCT). Severe aplastic anemia and very severe aplastic anemia are hematologic emergency as they have a mortality rate of greater than 70%. Therefore, treatment should be initiated immediately. 33 Gingival bleeding, absence of lympadenopathy and organomegaly in this case supports the diagnosis of acquired aplastic anemia but absence of congenital abnormalities, fever, symptoms of anemia and normal peripheral blood findings are the points against both acquired and congenital aplastic anemia.
Hemophilia
Hemophilia is mainly an inherited genetic disorder that hampers the capability of the body to make blood clot that is needed to stop bleeding. 40 The presence of oral bleeding in this girl is in favor of the diagnosis of hemophilia but sex of the patient, absence of bleeding disorders in the family as well as the absence of hemorrhage characteristic of hemophilia disfavor the diagnosis of hemophilia.
Vitamin K deficiency
Vitamin K is an important lipid-soluble vitamin which takes part in the vitamin K cycle for the production of vitamin K-dependent coagulation factors. Green, leafy-vegetables and oils such as soybean, cottonseed, canola and olive oils are the rich sources of vitamin K but colonic bacteria also synthesize it. 41 Four coagulation factors (FII, FVII. FIX, FX) in the liver are synthesized with the help of VK. Production of protein C and S, which are anticoagulant proteins, also depends on vitamin K. 42 The etiology of vitamin K deficiency differs in infants and adults. In infants, the notable cause is liver prematurity, lack of vitamin K in breast milk, sterile guts in neonates and low transplacental transfer of vitamin K. 
Dr. Aziz's Diagnosis

Von Willebrand disease
Discussion
Dr. Rahman: Von Willebrand disease is a congenital coagulation disorder caused by the deficiency of synthesis of defective Von Willebrand factor. As a result, the primary hemostatic defect ensues due to defective interaction between the platelets and the vessel walls. 50 Von Willebrand factor is a large multimeric glycoprotein, circulates in plasma at a concentration of 10 mg/dL and carries FVIII in a non-covalently bound complex. Von Willebrand factor plays vital roles in the synthesis, action, stabilization, conformation and immunogenicity of FVIII. 51 Von Willebrand factor is released from the storage granules in platelets and endothelial cells in response to various stimuli such as stress, estrogens, pregnancy, malignancy and thyrotoxicosis that cause endothelial activation.
Two main functions of the Von Willebrand factor are: a) It mediates the adhesion of platelets to the site of traumatized blood vessels and b) it fixes and stabilizes the FVIII, thereby preventing its degradation. The plasma half-life of FVIII in presence of normal Von Willebrand factor concentration is 12 hours but in the absence of the factor, the half-life of FVIII-C (FVIII-coagulant) is reduced to 2 hours. 52 Von Willebrand disease is categorized into three main types: a) type 1 (quantitative deficiency of Von Willebrand factor), b) type 2 (qualitative deficiency of Von Willebrand factor) and c) type 3 (complete deficiency of Von Willebrand factor). 53 The inheritance of the disease is autosomal dominant except type 3 which is inherited as autosomal recessive manner. The prevalence is only 1% in general population. About 125 persons per million populations are affected by clinically significant Von Willebrand disease but the prevalence of severe disease is approximately 0.5-5.0 persons per million population.
Males and females are equally affected but the phenotypic features are more frequently detected in women because of increased bleeding tendency during menstruation. ABO blood groups of the affected individual also determine severity of the Von Willebrand disease, being severe in people of blood group 'O'. 54 The incidence of type 1 disease is 60-80% of cases, type 2 disease 20-30% of cases and type 3 disease accounts for less than 5% of all cases. 55 Mutations in Von Willebrand factor gene which is situated on the short arm of chromosome 12 are responsible for the disease in most cases. More than 300 mutations have been detected in Von Willebrand factor gene. In severe cases, the genetic changes in Von Willebrand factor gene are common whereas in mild form of type 1, full range of molecular pathology together with polymorphisms of Von Willebrand factor gene may be seen. Individuals with type 1 disease have low levels of Von Willebrand factor due to mutations affecting the expression of Von Willebrand factor gene. As a result of mutations, the intracellular passage of Von Willebrand factor sub-units is impaired leading to severe, dominantly form of type 1. 56 In type 1, there is also rapid clearance of Von Willebrand factor from the plasma providing less cleavage time of circulating Von Willebrand factor multimer by ADAMTS-13. 57 In type 2, plasma Von Willebrand factor level is normal but have structural and functional defects on which basis type 2 is divided into four subtypes. Either defective Von Willebrand factor multimer assembly or increased cleavage of the multimer by ADAMTS -13 is responsible for type 2A disease. Homozygous or heterozygous mutations in Von Willebrand factor gene may result in defective multimer assembly preventing multimerization of Von Willebrand factor in the Golgi apparatus. As a result, there is selective loss of large and mediumsized multimers leading to decreased Von Willebrand factor mediated platelet adhesion. 58 Type 2B is characterized by the loss of large multimers. Multimer assembly is not hampered by the mutations that cause type 2B disease but the multimers after their secretion, get bound to the platelets after which they become cleaved by ADAMTS-13. The defect in type 2B is that Von Willebrand factor-Gp1b complex could not bind to subendothelial tissue. As a result, the large multimers-platelet Gp1b complex is rapidly cleared from the plasma resulting in thrombocytopenia. 59 Type 2M is characterized by decreased Von Willebrand factor dependant platelet adhesion but the plasma concentration of HMW Von Willebrand factor multimer is normal. The mutations that cause type 2M disease leads to a defect in the functions of Von Willebrand factor resulting in the interference of Von Willebrand factor-platelet adhesion.
As a result, there is less exposure of Von Willebrand factor to ADAMTS-13 preserving the large multimers of Von Willebrand factor in the same concentration as secreted from endothelial cells. 60 Von Willebrand disease type 2N is featured by remarkable decline in the binding affinity for FVIII due to mutations. The FVIII level is reduced and leads to the misdiagnosis of hemophilia A. Von Willebrand disease type 3 is caused by recessive mutations either missense or nonsense of the Von Willebrand factor gene resulting in undetectable plasma level of Von Willebrand factor. 61 Besides mutations, epigenetic factors such as ABO blood group causing defects in other genes may influence the circulating Von Willebrand factor level. 53 Type 3 Von Willebrand disease is a severe form of the three, characterized by severe mucosal bleeding, hemarthrosis and muscle hematoma and affect 1-2 per million populations. 62 Von Willebrand disease may be acquired resulting from the development of antibodies to Von Willebrand factor. Conditions that may cause acquired Von Willebrand disease are hypothyroidism, aortic stenosis, Eisenmenger syndrome, myeloproliferative disorders, Wilms tumor and IgG and IgM paraprotein. It develops by a variety of mechanisms in such acquired disorders but typically resolves with the treatment of the underlying disease or cause. 63 Several factors influence the symptoms of Von Willebrand disease: Plasma level of residual Von Willebrand factor activity, disease type and subtype and also age and sex of the patient. Bruising and epistaxis are the prominent symptoms in children with Von Willebrand disease. Pediatric-specific bleeding in Von Willebrand disease are cephalohematoma, cheek bleeding, post-circumcision and post-venipuncture bleeding, conjunctival bleeding and umbilical stump bleeding. 64 In adult the most common presenting symptoms are hematomas, menorrhagia and bleeding from minor wounds. Bleeding following surgery or dental extraction are the symptoms presented by majority (60-80%) of patients. 65 Five to 20% of women having menorrhagia are diagnosed as Von Willebrand disease 66 and on the other hand 70% of women with Von Willebrand disease have increased blood loss during menstrual cycle. 67 Although hemarthrosis is not a significant problem in patients with Von Willebrand disease but patients with type 2N and type 3 may present with hemarthrosis. Risk of joint bleeding depends on the level of residual Von Willebrand factor in plasma, severity of the disease and patients with type 3 Von Willebrand disease who has reduced FVIII level. 68 Von Willebrand factor rise physiologically throughout life but such age-dependant increase in Von Willebrand factor does not provide protection to alleviate bleeding symptoms. 69 However, patients with Von Willebrand disease are at reduced risk of developing cardiovascular disease and ischemic stroke. 70 The early diagnosis of Von Willebrand disease type 1 and type 2 is difficult as the patients do not present with major bleeding manifestations. Type 3 usually presents with severe bleeding, so early diagnosis is relatively simple and easy. The disease is usually diagnosed on the basis of personal and family history of bleeding along with laboratory test results. The first line laboratory investigations are: Estimation of hemoglobin level, hematocrit, platelet count, prothrombin time and activated partial thromboplastin time and more importantly Von Willebrand disease profile testing (VWF: Ag, VWF: RCo, FVIII: C), ABO blood group. Second line tests if initial test results suggest Von Willebrand disease are: Von Willebrand factor multimer analysis, VWF:CBA, VWF:FVIIIB, RIPA and Genetic tests. 71 In type 3, patients present with severe bleeding and laboratory investigations such as bleeding time is markedly prolonged, prothrombin time is normal, activated partial thromboplastin time is also prolonged. VWF: Ag and FVIII level are very low (≤5 IU/dL). 72 Though we could not perform genetic testing for the molecular confirmation of the Von Willebrand disease but the early onset of severe bleeding and absence of bleeding history in her family which are characteristics of autosomal recessive disorders along with normal platelet count, non-"O" blood group, markedly prolonged bleeding time, moderately prolonged activated partial thromboplastin time, markedly reduced VWF: Ag (3%) and FVIII level (3%) strongly suggests the Dr. Anisur Rahman Howlader: Is there any sex predilection for the incidence of Von Willebrand disease? As we know hemophilia A affects male only but can it affects female? Dr. Ismail Chowhdury: As Von Willebrand disease is inherited as autosomal recessive inheritance, so both sexes are equally affected. Though hemophilia is a disease of male but it may affect female in conditions such as Turner syndrome (XO) associated with affected hemophilia gene, extreme lyonization (inactivation of the normal FVIII allele in one of the X chromosome), homozygosity for the hemophilia gene (i.e., father with hemophilia and mother who is a carrier, two independent mutations, or some combination of inheritance and new mutations 
Dr. Muhammad Ariful Islam Miah (Medical Specialist):
Why Von Willebrand factor level is low in blood group "O" individuals?
Dr. Aleem: The underlying mechanism responsible for the low plasma level of FVIII and Von Willebrand factor in individuals with blood group O remains unknown. However, it has been assumed that the ABO effect is primarily mediated through a direct functional effect of the ABO locus on plasma Von Willebrand factor levels. Theoretically, ABO blood group may alter the rate of Von Willebrand factor synthesis or secretion within endothelial cells. Alternatively, ABO group may affect Von Willebrand factor plasma clearance rates. 78 Dr. Rahman: Why type 3 is more severe than type 1 disease?
Dr. Aziz: In type 3, the plasma level of FVIII and Von Willebrand factor are markedly reduced leading to the development of hemarthrosis and muscle hematoma. But in type 1 and type 2, the reduction of FVIII and Von Willebrand factor are not that much severe to cause hemarthrosis and muscle hematoma. 62 
Final Diagnosis
Von Willebrand disease type 3
